AGT and acute kidney injury: Angiotensin II is another promising non-catecholamine direct acting vasopressor that significantly increased blood pressure in patients with refractory hypotension [55], and improved survival in patients with acute kidney injury (AKI) requiring renal replacement therapy [56].